4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with emodin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bain, J; Battistutta, R; de Moliner, E; Elliott, M; Fabbro, D; Furet, P; Meggio, F; Pagano, MA; Pinna, LA; Ruzzene, M; Sarno, S; Schoepfer, J; Zanotti, G | 1 |
| Hirasawa, A; Kinoshita, T; Kitaura, K; Nakanishi, I; Nakaniwa, T; Sekiguchi, Y; Tada, T; Tsujimoto, G | 1 |
| Bednarski, P; Götz, C; Hemmerling, HJ; Hundsdörfer, C; Jose, J; Le Borgne, M; Totzke, F | 1 |
| Alvarez, L; Baratin, S; Bollacke, A; Desplat, V; Guillon, J; Jose, J; Le Borgne, M; Marchivie, M; Moreau, S; Pecci, A; Pinaud, N; Rimbault, C; Roche, S; Savrimoutou, S | 1 |
| Aichele, D; Bollacke, A; Bouaziz, Z; Cadena, SM; Daflon-Yunes, N; Di Pietro, A; Guillon, J; Jabor Gozzi, G; Jose, J; Lacoudre, A; Le Borgne, M; Marminon, C; Nacereddine, A; Pinaud, N; Valdameri, G; Winter, E; Zeinyeh, W | 1 |
| Hirasawa, A; Iwamoto, N; Kinoshita, T; Kitaura, K; Kurono, M; Miyazaki, T; Murata, K; Nagata, N; Nakamura, S; Nakanishi, I; Nakaniwa, T; Nishiwaki, K; Sakurai, A; Sekiguchi, Y; Takei, Y; Tsujimoto, G; Yasue, M | 1 |
| Chen, T; Chen, Y; Feng, F; Guo, Q; Lin, H; Liu, W; Liu, Z; Qiao, Y; Qu, W; Sun, H; Yang, H | 1 |
| Bardine, C; Craik, CS; O'Donnell, HR; Shoichet, BK; Tummino, TA | 1 |
| Davies, SP; Donella-Deana, A; Meggio, F; Pinna, LA; Reddy, H; Ruzzene, M; Sarno, S; Shugar, D | 1 |
| Battistutta, R; De Moliner, E; Pinna, LA; Sarno, S; Zanotti, G | 1 |
| Götz, C; Gratz, A; Jose, J | 1 |
1 review(s) available for 4,5,6,7-tetrabromo-2-azabenzimidazole and emodin
| Article | Year |
|---|---|
Small molecule modulators targeting protein kinase CK1 and CK2.
Topics: Animals; Casein Kinase I; Casein Kinase II; Drug Discovery; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Small Molecule Libraries | 2019 |
10 other study(ies) available for 4,5,6,7-tetrabromo-2-azabenzimidazole and emodin
| Article | Year |
|---|---|
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
Topics: Acetates; Animals; Casein Kinase II; Cell Line; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Jurkat Cells; Molecular Structure; Plant Proteins; Protein Serine-Threonine Kinases; Protein Structure, Quaternary; Quinazolines; Rats; Zea mays | 2003 |
Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
Topics: Adenosine Triphosphate; Binding Sites; Casein Kinase II; Catalytic Domain; Crystallography, X-Ray; Ellagic Acid; Enzyme Inhibitors; Humans; Protein Structure, Tertiary | 2009 |
Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors.
Topics: Casein Kinase II; Cell Membrane Permeability; Humans; Indoles; Kinetics; Protein Kinase Inhibitors; Stereoisomerism | 2012 |
Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2.
Topics: Casein Kinase II; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrroles; Quinoxalines; Structure-Activity Relationship | 2013 |
Converting potent indeno[1,2-b]indole inhibitors of protein kinase CK2 into selective inhibitors of the breast cancer resistance protein ABCG2.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Casein Kinase II; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; HEK293 Cells; Humans; Indoles; MCF-7 Cells; Mitoxantrone; Models, Chemical; Molecular Structure; Neoplasm Proteins; Protein Kinase Inhibitors | 2015 |
Identification of protein kinase CK2 inhibitors using solvent dipole ordering virtual screening.
Topics: Casein Kinase II; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Activation; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Solvents; Structure-Activity Relationship | 2015 |
Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens.
Topics: Antiviral Agents; COVID-19 Drug Treatment; Drug Repositioning; Molecular Docking Simulation | 2021 |
Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2').
Topics: Adenosine Triphosphate; Amino Acid Substitution; Binding Sites; Binding, Competitive; Casein Kinase II; Emodin; Enzyme Inhibitors; Humans; Jurkat Cells; Protein Kinases; Protein Serine-Threonine Kinases; Staurosporine; Substrate Specificity; Triazoles | 2001 |
Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole.
Topics: Adenosine Triphosphate; Binding Sites; Casein Kinase II; Emodin; Enzyme Inhibitors; Guanosine Triphosphate; Models, Molecular; Protein Serine-Threonine Kinases; Triazoles; Zea mays | 2001 |
A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease.
Topics: Casein Kinase II; Emodin; Enzyme Assays; Fluorescence; Fluorescence Resonance Energy Transfer; Humans; Naphthalenesulfonates; Neoplasms; p-Dimethylaminoazobenzene; Pancreatic Elastase; Peptides; Phosphorylation; Protein Kinase Inhibitors; Sensitivity and Specificity; Triazoles | 2010 |